PUBLISHER: Grand View Research | PRODUCT CODE: 1631503
PUBLISHER: Grand View Research | PRODUCT CODE: 1631503
The global penile implants market size is estimated to reach USD 817.0 million by 2030, registering to grow at a CAGR of 7.1% from 2025 to 2030 according to a new report by Grand View Research, Inc. Increasing incidence of Erectile Dysfunction (ED) disorder on a global level as a symptom of associated comorbidities such as diabetes, renal disease, liver disorder, vascular conditions, and atherosclerosis, is a key factor driving the market.
Erectile Dysfunction (ED) is a very common problem among men aged 30 years and above. An article from the Massachusetts Male Aging Study states that around 52.0% of men experience some form of ED and that total ED increases from about 5 to 15% between ages 40 and 70. The development of advanced penile implants/prostheses for surgical treatment of ED is another major factor driving the market. For instance, in July 2019, Boston Scientific launched its new malleable Tactra penile implant to treat erectile dysfunction. Most of the penile procedures can be carried in an ambulatory setting thus, reducing the need for hospital admissions.